112 related articles for article (PubMed ID: 2155503)
1. Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.
Christensen ND; Kreider JW; Cladel NM; Galloway DA
Virology; 1990 Mar; 175(1):1-9. PubMed ID: 2155503
[TBL] [Abstract][Full Text] [Related]
2. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.
Christensen ND; Kreider JW; Kan NC; DiAngelo SL
Virology; 1991 Apr; 181(2):572-9. PubMed ID: 1707567
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
4. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
5. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
6. Reactivities of polyclonal and monoclonal antibodies raised to the major capsid protein of human papillomavirus type 16.
Patel D; Shepherd PS; Naylor JA; McCance DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():69-77. PubMed ID: 2543739
[TBL] [Abstract][Full Text] [Related]
7. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.
Jenison SA; Firzlaff JM; Langenberg A; Galloway DA
J Virol; 1988 Jun; 62(6):2115-23. PubMed ID: 2835513
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions.
Christensen ND; Kreider JW
Virus Res; 1991 Nov; 21(3):169-79. PubMed ID: 1722596
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
[TBL] [Abstract][Full Text] [Related]
10. Colocalization of human papillomavirus type 11 E1[symbol: see text]E4 and L1 proteins in human foreskin implants grown in athymic mice.
Brown DR; Fan L; Jones J; Bryan J
Virology; 1994 May; 201(1):46-54. PubMed ID: 8178488
[TBL] [Abstract][Full Text] [Related]
11. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions.
Christensen ND; Kreider JW; Shah KV; Rando RF
J Gen Virol; 1992 May; 73 ( Pt 5)():1261-7. PubMed ID: 1316943
[TBL] [Abstract][Full Text] [Related]
12. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Dillner L; Heino P; Moreno-Lopez J; Dillner J
J Virol; 1991 Dec; 65(12):6862-71. PubMed ID: 1719234
[TBL] [Abstract][Full Text] [Related]
13. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3081-9. PubMed ID: 2826650
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.
Rose RC; White WI; Li M; Suzich JA; Lane C; Garcea RL
J Virol; 1998 Jul; 72(7):6151-4. PubMed ID: 9621080
[TBL] [Abstract][Full Text] [Related]
15. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.
Rose RC; Bonnez W; Strike DG; Reichman RC
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2725-9. PubMed ID: 2174962
[TBL] [Abstract][Full Text] [Related]
16. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
17. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides.
Lim PS; Jenson AB; Cowsert L; Nakai Y; Lim LY; Jin XW; Sundberg JP
J Infect Dis; 1990 Dec; 162(6):1263-9. PubMed ID: 1700026
[TBL] [Abstract][Full Text] [Related]
18. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
19. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
